Mark McGregor

Manchester

Digital News Editor at BBC

Digital News Editor @ BBC News.

Featured in: Favicon

linkedin.com Favicon

forbes.com Favicon

techradar.com Favicon

thelancet.com Favicon

martechseries.com Favicon

wardsauto.com Favicon

futuremedicine.com Favicon

propertycasualty360.com Favicon

demandgenreport.com + 9 more

Articles

A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liver - British Journal of Cancer

1 month ago | nature.com | Timothy J Price |Mark McGregor |Laura Depauw |Gabrielle Cehic |Anas Alawawdeh

AbstractMetastatic neuroendocrine neoplasms (mNEN) require new treatment options. Intralesional (IL) PV-10 is an autolytic chemotherapy that may elicit an adaptive immune response. This phase 1 study evaluated IL PV-10 administered percutaneously to hepatic lesions in patients with progressive mNEN. IL PV-10 was injected in a single lesion per treatment cycle. A treatment cycle could be repeated after ≥ 6 weeks if multiple targetable lesions were present. The primary endpoint was safety.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 491
Tweets: 4K
DMs Open: Yes

No Tweets found.